Innoviva (INVA) Shares Outstanding (2009 - 2026)
Innoviva (INVA) reported Shares Outstanding of $73.8 million for Q1 2026, up 17.58% on a YoY basis from $62.8 million in Q1 2025, and down 1.11% quarter-over-quarter from $74.6 million in Q4 2025.
Innoviva (INVA) Shares Outstanding (2009 - 2026) Analysis & Trends
Innoviva has reported Shares Outstanding for 18 years, with the latest figure at $73.8 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding rose 17.58% year-over-year to $73.8 million; the trailing twelve-month figure through Mar 2026 stood at $73.8 million (up 17.58% YoY), and the FY2025 full-year result was $74.6 million, up 19.1% from the prior year.
- Shares Outstanding for Q1 2026 stood at $73.8 million, down from $74.6 million in the prior quarter.
- The five-year high for Shares Outstanding was $74.8 million in Q3 2025, with the low at $69776.0 in Q3 2022.
- Historically, Shares Outstanding has averaged $56.4 million across 5 years, with a median of $62.8 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding tumbled 99.9% — and 2023, when it soared 92172.41%.
- Innoviva's Shares Outstanding stood at $69.2 million in 2022, then dropped by 8.5% to $63.3 million in 2023, then decreased by 1.01% to $62.7 million in 2024, then climbed by 19.1% to $74.6 million in 2025, then slipped by 1.11% to $73.8 million in 2026.
- The last three Shares Outstanding figures came in at $73.8 million (Q1 2026), $74.6 million (Q4 2025), and $74.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 91.57 Bn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Innoviva | 1.69 Bn | 1.08 Bn | 75.83 Mn | 73.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.81 Mn |
| Mar 31, 2026 | 73.81 Mn |
| Mar 31, 2026 | 73.81 Mn |
| Mar 31, 2026 | 73.81 Mn |
| Mar 31, 2026 | 73.81 Mn |
| Mar 31, 2026 | 73.81 Mn |
| Mar 31, 2026 | 73.81 Mn |
| Mar 31, 2026 | 73.81 Mn |
| Dec 31, 2025 | 74.64 Mn |
| Dec 31, 2025 | 74.64 Mn |
| Dec 31, 2025 | 74.64 Mn |
| Dec 31, 2025 | 74.64 Mn |
| Dec 31, 2025 | 74.64 Mn |
| Dec 31, 2025 | 74.64 Mn |
| Dec 31, 2025 | 74.64 Mn |
| Dec 31, 2025 | 74.64 Mn |
| Sep 30, 2025 | 74.77 Mn |
| Sep 30, 2025 | 74.77 Mn |
| Sep 30, 2025 | 74.77 Mn |
| Sep 30, 2025 | 74.77 Mn |